Back to top
more

Alignment Healthcare (ALHC)

(Delayed Data from NSDQ)

$5.26 USD

5.26
2,438,188

+0.04 (0.77%)

Updated May 2, 2024 04:00 PM ET

After-Market: $5.29 +0.03 (0.57%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Compared to Estimates, Alignment Healthcare (ALHC) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -4.17% and 5.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Will Ascend Wellness Holdings, Inc. (AAWH) Report Negative Earnings Next Week? What You Should Know

Ascend Wellness Holdings, Inc. (AAWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline

Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alignment Healthcare (ALHC) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Stay Ahead of the Game With Alignment Healthcare (ALHC) Q4 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alignment Healthcare (ALHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.

Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Cheniere (LNG) Pull Off a Strong Show in Q4 Earnings?

Robust export volumes and lower costs are likely to have boosted Cheniere Energy's (LNG) profit levels in the fourth quarter.

Factors to Note Ahead of Coterra Energy's (CTRA) Q4 Earnings

Coterra Energy (CTRA) beat the Zacks Consensus Estimate for earnings in each of the last four quarters, resulting in an earnings surprise of 111.8%, on average.

Alignment Healthcare (ALHC) Expected to Beat Earnings Estimates: Should You Buy?

Alignment Healthcare (ALHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kaibalya Pravo Dey headshot

Analyzing 3 Healthcare Stocks Poised for Q4 Earnings Beat

Rising patient volumes, admissions, health awareness and technological advancements in the Q4 are likely to have benefited healthcare players like Universal Health (UHS), Alignment Healthcare (ALHC) and Agiliti (AGTI).

Alignment Healthcare (ALHC) Moves 13.2% Higher: Will This Strength Last?

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alignment Healthcare (ALHC) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Alignment Healthcare (ALHC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Alignment Healthcare (ALHC) Surges 17.2%: Is This an Indication of Further Gains?

Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 28.57% and 5.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

CareDx (CDNA) Soars 20.6%: Is Further Upside Left in the Stock?

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 20% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Alignment Healthcare (ALHC): Can Its 6.5% Jump Turn into More Strength?

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -3.33% and 6.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of -12.50% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Alignment Healthcare (ALHC) Reports Q3 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 12% and 8%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit

Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.

UnitedHealth (UNH) Wins New Medicaid Contract in Nebraska

UnitedHealth's (UNH) UnitedHealthcare boasts a network of 100 hospitals and more than 14,000 physicians and caregivers in Nebraska.